2014-09-18-德勤-医学事务在中国的转变_16页_1mb

Summary of "Transforming Medical Affairs in China"

Core Content

The document outlines the transformation of Medical Affairs in the Chinese pharmaceutical market, emphasizing the need for a strategic shift in how Medical functions are structured, managed, and integrated within multinational companies (MNCs). It highlights the increasing importance of Medical Affairs in addressing evolving market dynamics, regulatory pressures, and the demand for evidence-based decision making.

Main Trends and Changes

• Growth in Medical Staff: MNCs in China are experiencing rapid growth in Medical personnel, with increases of 20% or more annually, driven by the need to support new products and complex market environments.
• Role Expansion: Medical Affairs is moving beyond traditional support roles (e.g., pharmacovigilance, compliance, promotional materials review) to become a strategic function that influences product strategy, market access, and competitive differentiation.
• Regulatory Shifts: Increased regulatory scrutiny has led to a reduced role for sales teams in engaging with physicians, creating a need for Medical to take on a more active, compliant, and scientifically driven communication role.
• Evidence-Based Decision Making: Stakeholders in China, including physicians, hospitals, and governments, are increasingly relying on scientific evidence for decision-making. This necessitates Medical's role in generating and communicating robust evidence.
• Competition and Market Complexity: The market is becoming more competitive, with slower overall growth and a focus on product strategy rather than market expansion. Medical is now a key contributor to competitive intelligence and strategy development.
• Talent Shortages and Retention: Medical personnel are in high demand, with high turnover rates. Companies must invest in professional development, clear career paths, and alignment of incentives to retain top talent.
• Market Engagement: Medical is increasingly responsible for engaging with key opinion leaders (KOLs), participating in advisory boards, and leading scientific discussions and publications.

Key Activities and Responsibilities

• Strategic Insight: Medical must become an active participant in strategy development, providing insights on disease epidemiology, competitive intelligence, and product lifecycle management.
• Evidence Generation: Medical is expected to take ownership of post-marketing trials, clinical research, and evidence-based publications, especially for branded generics.
• KOL Relationship Management: Medical is now a primary owner of top-tier KOL relationships, responsible for identifying, mapping, and engaging with key scientific leaders.
• Patient and Stakeholder Communication: Medical is tasked with creating patient education programs, supporting government affairs, and ensuring compliance with evolving regulations.

The New Strategic Vision for Medical Affairs

An effective Medical Affairs organization in China should possess four key characteristics:

1. Clear Mission and Strategic Mandate: Defined roles that align with both R&D and Commercial functions.
2. Defined Activities and Responsibilities: A broad range of activities that extend beyond traditional roles.
3. Operational Protocols and Collaboration: Systems that enable effective collaboration with other business units and external stakeholders.
4. Enabling Systems: Tools and processes that align employee incentives with company objectives.

The Medical Field Force

• MSLs (Medical Science Liaisons): These professionals are critical in proactive physician engagement, competitive intelligence, and market shaping.
• Structure and Integration: Companies must define the structure and reporting lines of the Medical Field Force to ensure it operates distinctively from the sales force.
• Role in Strategy Development: MSLs are expected to provide insights that inform product strategy and competitive differentiation.

Enabling Systems for Medical Affairs

• Performance Metrics and KPIs: Essential for measuring the impact of Medical functions.
• Culture and Leadership: Strong leadership and a professional culture are vital for attracting and retaining talent.
• Rewards and Recognition: Incentive structures that motivate Medical staff to perform at their best.
• Talent Management: Systems for training, development, and capability building.
• CRM Systems: Tools to support relationship management with KOLs and other stakeholders.

Benefits of Transformation

• Stronger Product Strategies: Medical insights lead to more effective and patient-centered strategies.
• Accelerated Time to Market: Better understanding of unmet needs and physician expectations reduces time to market.
• Improved Commercial Effectiveness: Evidence-based support enhances physician trust and product acceptance.
• Cost Efficiency: Reduces duplication of effort and improves resource allocation.
• Enhanced Stakeholder Relationships: Builds trust and credibility with KOLs, physicians, and the government.

Five Factors Driving the Need for Change

1. Tightening Regulation and Compliance: Sales teams are increasingly restricted, pushing Medical to take on more communication responsibilities.
2. From Origination to Innovation: Branded generics are being replaced by innovative products, requiring Medical to support market shaping and evidence communication.
3. Science-Driven Relationships: Physicians are shifting from relationship-based to evidence-based decision-making, increasing the need for Medical engagement.
4. Shifting Decision Power: Patients and institutional guidelines are influencing clinical decisions, requiring Medical to communicate clinical and economic value effectively.
5. Demand for Value: Therapies are now evaluated based on their value to patients relative to healthcare costs, necessitating strong evidence generation and communication.

Conclusion

The transformation of Medical Affairs in China is essential to remain competitive and compliant in a rapidly evolving market. Companies must invest in strategic vision, operational integration, and enabling systems to fully realize the potential of their Medical teams. This shift not only enhances the value of Medical but also improves overall business performance and stakeholder engagement.